1009224
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- March 3, 2017
- Fiscal Year
- 2017
- Product Type
- Biologics
- Project Area
- Blood and Blood Products
- Location
- New York, NY (United States)
Citations
| ID | CFR | Description |
|---|---|---|
| 12221 | 21 CFR 1271.47(a) | Procedures for all other requirements |
| 12278 | 21 CFR 1271.75(a)(2) | Risks associated with xenotransplantation |